Serina Therapeutics, Inc. (SER) AMEX
1.99
-0.04(-1.97%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.99
-0.04(-1.97%)
Currency In USD
| Market Cap | 19.46M |
| Enterprise Value | 16.6M |
| P/E Ratio | -1.06 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 153.08 |
| Price/Book Ratio | -548.06 |
| Enterprise/Revenue | 153.74 |
| Enterprise/EBITDA | -0.91 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -147.55 |
| Operating Margin | -184.78 |
| Return On Assets | -2.76 |
| Return On Equity | -14.68 |
| Revenue | 130,000 |
| Revenue/Share | 0.01 |
| Gross Profit | 45,000 |
| EBITDA | -24.02M |
| Net Income | -19.18M |
| Diluted EPS | -1.91 |
| Total Cash | 3.06M |
| Total Cash/Share | 0.47 |
| Total Debt | 3.14M |
| Total Debt/Equity | -84.92 |
| Current Ratio | 1.71 |
| Book Value Per Share | -0 |
| 52-Week Change | -62.1 |
| 52-Week High | 7.92 |
| 52-Week Low | 1.22 |
| Moving Average 50 Days | 1.95 |
| Moving Average 200 Days | 3.78 |
| Average Volume | 4.61M |
| Shares Outstanding | 10M |
| % Held by Institutions | 4.16 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 7:250 |
| Last Split Date | March 15, 2024 |